Dr. Robert Popovian is the Founder of the strategic consulting firm Conquest Advisors. He also serves as Chief Science Policy Officer at the Global Healthy Living Foundation. One of the country’s foremost experts on every significant facet of biopharmaceuticals and the healthcare industry, he is a recognized authority on health economics, policy, government relations, and medical affairs. Dr. Popovian has published extensively and has been cited in the most prominent medical sources and media outlets, including the Wall Street Journal. Dr. Popovian is Chairman of the Board of Councilors at the Mann School of Pharmacy and Pharmaceutical Sciences at USC, and an Adjunct Clinical Assistant Professor at Rutgers School of Pharmacy. Dr. Popovian completed his Doctorate in Pharmacy and Master of Science in Pharmaceutical Economics and Policy degrees with honors at the University of Southern California.

Dr. Wayne Winegarden is a Sr. Fellow in Business and Economics with the Pacific Research Institute, Director of the Center for Medical Economics and Innovation at PRI, and the Principal of Capitol Economic Advisors. Dr. Winegarden’s consulting practice advises clients on the impacts of fiscal and economic policies on business outcomes. His economic research focuses on regulatory, fiscal, macroeconomic, health, and energy policies. In addition to his Southern California News Group column, Dr. Winegarden’s editorials have been published in outlets such as the Orange County Register, USA Today, the Wall Street Journal, and the Hill. Dr. Winegarden has testified before the U.S. Congress; was previously an economics faculty member at Marymount University; worked as a business economist in Hong Kong and New York City; and worked as a policy economist for policy and trade associations in Washington, D.C. He received his Ph.D. in Economics from George Mason University.